Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 7, 2004

View Archived Issues

Isovaleramide advances into phase IIa study in migraine

Phase Ib study evaluates aerosolized surfactant therapy for asthma

Axonyx expands scope of phenserine phase IIb clinical trial

Confirmatory data supports phase II Resten-NG data

Five years exclusive Indian marketing rights for Nadoxin

Uni-Gold Recombigen HIV test receives FDA approval

Symbyax approved for bipolar depressive episodes

NDA submission for once-daily Allegra-D

ISIS-301012 enters phase I study for treatment of cardiovascular disease

Pharmion submits Vidaza NDA

Neurodex evaluated for pseudobulbar affect

Aventis scientists prepare and test new cathepsin K inhibitors

Kirin Brewery presents new inhibitors of Bcl-2/Bcl-xL with utility in cancer therapy

Novel libraries of antibacterial compounds prepared at Lion Bioscience

Mitsui Chemicals patent covers new agents for telomerase-mediated disorders

New antitumor azoles in early development at Sankyo

Coremed plans clinical trials for Alveair insulin technology

Alvesco NDA submission for persistent asthma

Shipments of TriNessa commence

DX-88 meets primary endpoints in phase I/II study

Japanese trials of HGF genetic medicine cleared to begin

Nascobal Nasal Spray submitted for FDA approval

AVI-4020 safe in phase I/II West Nile trial

Kyorin discontinues development of KRP-297

NDA filing for Arcoxia

Ivabradine has no adverse effects on the LVEF of patients with left ventricular dysfunction

Prolonged inhibition of spermatogenesis found with subcutaneous MENT implants

A novel triple therapy improves glucose metabolism in obese patients with type 2 diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...